STAREE Trial: Atorvastatin Reduces Heart Attack Risk in Older Adults

The STAREE clinical trial has demonstrated that atorvastatin reduces the risk of major cardiovascular events by 30% in healthy adults aged over 70.

While the drug successfully lowered heart attack and stroke rates, the study noted that it did not significantly impact disability-free survival goals.

The findings provide strong evidence for the use of statins in older populations, potentially changing clinical practice for preventative cardiovascular care.